MedTrace Logo

Health Status and Quality of Life in the Elderly

NCT01953172 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-03-11

No results posted yet for this study

Summary

The study is designed to investigate the effect of AMP886 (alpha-tocotrienol) on health status and quality of life measures, cognitive functioning, oxidative stress, inflammation markers and other symptoms effects on skin, sleep and vision in the elderly.

Conditions

  • Quality of Life

Interventions

DIETARY_SUPPLEMENT

AMP-886

AMP886 (alpha-tocotrienol) encapsulated in gelatin capsules

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Sprim Advanced Life Sciences

    collaborator OTHER

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • C Verhoeven, PhD · Unilever Research and Development

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01953172 on ClinicalTrials.gov